OpiCalc

Favorites Specialties Drugs Guidelines Most Used

All Specialties

Favorites Specialties Drugs Guidelines Most Used

Faves Specs Drugs Guides Top

APGAR Score Assisted Delivery (FIGO)BPP (Manning Score)Bishop Score CARPREG II Cardiac Risk Cervical Cancer Staging Contraceptive Pearl Index Doppler Matrix (UA/MCA)EFW (Hadlock)Endometrial Staging Endometrial Thickness FGR Criteria (Consensus)FSFI (Sexual Function)Ferriman-Gallwey Score Fetal Anemia (MCA PSV)GDM Diagnostic Criteria GPA History Indicator Gail Model Breast Risk Gestational Dating (LMP)HIV PMTCT Protocol IOTA Simple Rules IVF Due Date & AMH Iron Deficit (Ganzoni)Labour Progress (WHO)Maternal Sepsis (qSOFA)O-RADS Classification Ovarian Cancer Staging PAS Hemorrhage Risk PPH Protocol (FIGO)Preeclampsia (ACOG)Rho(D) Dose (K-B)Rotterdam PCOS Criteria Syphilis Management TORCH Framework VBAC Success Probability Vulvar Cancer Staging Weight Gain (IOM)mWHO Cardiac Risk

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required

Ready for the Bedside

Resources

About Us Editorial Policy Medical Disclaimer Privacy Policy Terms of Use Cookie Policy

Support

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

In Recent Clinical News

Scanning Medical Journals

No new significant updates or guidelines matching this topic were found today. We will check again soon.

FSFI (Sexual Function)

FSFI: Sexual Function Index

Validated Screening (Rosen et al.)

Desire (x 0.6)

Frequency/Level of interest

Score

Arousal (x 0.3)

Frequency/Level of excitement

Score

Lubrication (x 0.3)

Difficulty/Frequency

Score

Orgasm (x 0.3)

Frequency/Satisfaction

Score

Satisfaction (x 0.4)

Closeness/Confidence

Score

Pain (x 0.4)

During/After intercourse

Score

Total FSFI Score

11.5

POSSIBLE SEXUAL DYSFUNCTION (≤26.5)

Clinical Note: The FSFI is a multi-dimensional assessment. Total score ≤ 26.55 is the standard clinical threshold for identifying women with female sexual dysfunction.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

Primary Clinical Uses

Baseline assessment and screening tool for identifying Female Sexual Dysfunction (FSD)

Measuring therapeutic efficacy of interventions (e.g., localized estrogen, ospemifene, flibanserin)

Research standard for quantifying multidimensional sexual function in clinical trials

What it Measures

The FSFI is uniquely potent because it disaggregates sexual function into 6 distinct physical and psychological domains over the past 4 weeks: Desire, Arousal, Lubrication, Orgasm, Satisfaction, and Pain.

Last Comprehensive Review: 2026